Maccura Biotechnology Co.Ltd (SHE:300463)
China
· Delayed Price · Currency is CNY 12.01
-0.10 (-0.83%)
Jun 5, 2025, 2:45 PM CST
SHE:300463 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 7,302 | 8,010 | 9,230 | 10,596 | 16,243 | 25,961 | Upgrade
|
| Market Cap Growth | 1.98% | -13.22% | -12.89% | -34.77% | -37.43% | 72.60% | Upgrade
|
| Enterprise Value | 7,432 | 7,896 | 9,092 | 10,210 | 17,255 | 27,243 | Upgrade
|
| Last Close Price | 12.00 | 13.08 | 14.73 | 16.57 | 27.28 | 43.15 | Upgrade
|
| PE Ratio | 242.21 | 63.17 | 29.53 | 14.96 | 16.98 | 32.70 | Upgrade
|
| Forward PE | 25.00 | 16.54 | 17.39 | 12.45 | 14.61 | 31.12 | Upgrade
|
| PS Ratio | 2.99 | 3.14 | 3.19 | 2.94 | 4.08 | 7.01 | Upgrade
|
| PB Ratio | 1.14 | 1.25 | 1.40 | 1.62 | 3.58 | 6.48 | Upgrade
|
| P/TBV Ratio | 1.22 | 1.35 | 1.55 | 1.80 | 3.98 | 7.24 | Upgrade
|
| P/FCF Ratio | - | - | 391.01 | - | 16.01 | 43.80 | Upgrade
|
| P/OCF Ratio | 10.67 | 12.64 | 10.24 | 12.57 | 10.05 | 23.73 | Upgrade
|
| EV/Sales Ratio | 3.04 | 3.10 | 3.14 | 2.83 | 4.34 | 7.36 | Upgrade
|
| EV/EBITDA Ratio | 17.64 | 16.18 | 14.51 | 9.56 | 11.80 | 22.11 | Upgrade
|
| EV/EBIT Ratio | 91.86 | 46.99 | 27.42 | 12.52 | 13.91 | 26.53 | Upgrade
|
| EV/FCF Ratio | -30.91 | - | 385.18 | - | 17.00 | 45.96 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.10 | 0.10 | 0.11 | 0.25 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 2.03 | 1.31 | 1.03 | 0.65 | 0.76 | 1.07 | Upgrade
|
| Debt / FCF Ratio | - | - | 28.18 | - | 1.10 | 2.23 | Upgrade
|
| Asset Turnover | 0.30 | 0.32 | 0.36 | 0.49 | 0.62 | 0.63 | Upgrade
|
| Inventory Turnover | 1.24 | 1.40 | 1.42 | 1.62 | 1.62 | 1.87 | Upgrade
|
| Quick Ratio | 1.83 | 1.96 | 2.69 | 3.14 | 1.97 | 1.51 | Upgrade
|
| Current Ratio | 2.96 | 3.04 | 3.77 | 4.34 | 2.94 | 2.24 | Upgrade
|
| Return on Equity (ROE) | 0.30% | 1.82% | 4.64% | 12.68% | 23.45% | 22.40% | Upgrade
|
| Return on Assets (ROA) | 0.63% | 1.31% | 2.54% | 6.92% | 11.99% | 10.82% | Upgrade
|
| Return on Capital (ROIC) | 0.69% | 1.46% | 2.86% | 7.91% | 14.12% | 12.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.20% | 2.50% | 4.70% | 11.50% | 23.60% | 22.50% | Upgrade
|
| Earnings Yield | 0.42% | 1.58% | 3.39% | 6.68% | 5.89% | 3.06% | Upgrade
|
| FCF Yield | -3.29% | -4.11% | 0.26% | -1.36% | 6.25% | 2.28% | Upgrade
|
| Dividend Yield | 0.86% | 0.80% | 1.04% | 2.11% | 1.73% | 1.00% | Upgrade
|
| Payout Ratio | 376.18% | 90.84% | 78.26% | 44.97% | 31.00% | 13.28% | Upgrade
|
| Buyback Yield / Dilution | -0.10% | -0.01% | -0.77% | -9.16% | 0.11% | 0.05% | Upgrade
|
| Total Shareholder Return | 0.76% | 0.78% | 0.28% | -7.05% | 1.83% | 1.05% | Upgrade
|
Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.